Wednesday, April 29th, 2009 - Gene Expression Ratio Test Predicts Post-Surgery Outcome in Mesothelioma
Archive for the 'Mesothelioma Blood Test' Category
Monday, December 29th, 2008 - Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Friday, November 2nd, 2007 - Fujirebio Diagnostics Honored with Pioneer Award from Meso Foundation: MESOMARK® Test Recognized for Monitoring Patients with Asbestos-linked Cancer
Monday, April 23rd, 2007 - NYU Medical Center Partners With Rosetta Genomics to Develop a Line of Diagnostic Tools for Lung and Mesothelioma Cancers
Monday, March 26th, 2007 - CISBIO Announces FDA Approval of MESOMARK®; Assay Now Available to Physicians in the U.S. for Monitoring Patients with Mesothelioma
Monday, March 12th, 2007 - NYU Study Validates Use Of Fujirebio Diagnostics’ MESOMARK Test For Monitoring An Asbestos-Linked Cancer
Friday, October 14th, 2005 - Elevated Blood Levels of a Protein are Linked to Asbestos-induced Cancers
Thursday, October 13th, 2005 - New Study Shows Promise in a Finding a Blood Test to Detect Mesothelioma
Thursday, September 15th, 2005 - Ground-Breaking Mesothelioma Detection Study Begins – Libby, MT Residents Participating in Mesothelioma Applied Research Foundation (MARF) Funded Research into Mesothelioma Serum Marker
Thursday, April 14th, 2005 - Fujirebio Diagnostics Expands Commercial Availability of First Blood Test for Mesothelioma: Announces Distribution Agreement with Cisbio international to Bring MESOMARK™ to Europe
Thursday, March 3rd, 2005 - Fujirebio Diagnostics Launches First Blood Test for Mesothelioma: Vital Diagnostics to Make Test Commercially Available in Australia
Thursday, November 13th, 2003 - Asbestos cancer breakthrough: First-ever blood test for mesothelioma being developed
